PER
Click for more information
1.22% 8.1¢ percheron therapeutics limited

I am really puzzled and I would like to know if someone can help...

  1. Insulsa
    75 Posts.
    lightbulb Created with Sketch. 24
    clock Created with Sketch.
    22/06/24
    23:01
    Post #: 74442217
    I am really puzzled and I would like to know if someone can help me to clarify. AKKI when post something referring PER one way or another is always negative never post anything good about PER and no one among PER share holders has ever tried to contradict and/or at least ask to explain why this continuous negativity.
    Then today made a couple of post about Sarepta FDA approval and he gets great amount of thumbs up.
    What did I miss????
    PER Price at posting: 8.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.001(1.22%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.0¢ 8.3¢ 8.0¢ $52.59K 651.3K

Buyers (Bids)

No. Vol. Price($)
1 56645 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 109832 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.